Literature DB >> 25342087

Moyamoya syndrome associated with hemoglobin Southampton (Casper).

Nader Delavari1, Jennifer Strahle, Cormac O Maher.   

Abstract

When moyamoya vasculopathy results from an associated disease, this vasculopathy is then referred to as moyamoya syndrome. Moyamoya syndrome has been reported in association with sickle cell disease, neurofibromatosis type 1, Down syndrome, radiation exposure, and other predisposing factors. Other than sickle cell disease, rare hemoglobinopathies, such as hemoglobin Fairfax and hemoglobin Alesha, have been reported to occur with moyamoya. We present a case of moyamoya syndrome associated with an unstable hemoglobinopathy, hemoglobin Southampton (Casper). This is the first reported case of moyamoya associated with this hemoglobinopathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25342087     DOI: 10.1159/000367973

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  4 in total

1.  Metabolic Biomarkers of Aging and Aging-related Diseases in Chinese Middle-Aged and Elderly Men.

Authors:  W Liu; Y Liu; Y Yang; W Ou; X Chen; B Huang; H Wang; M Liu
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

Review 2.  Research Progress of Moyamoya Disease in Children.

Authors:  Jianmin Piao; Wei Wu; Zhongxi Yang; Jinlu Yu
Journal:  Int J Med Sci       Date:  2015-07-03       Impact factor: 3.738

3.  Another Rare Unstable Hemoglobinopathy: Hemoglobin Casper/Southampton Associated with Moyamoya Disease.

Authors:  Asim Haque; Douglas J Quint; Valerie P Castle; Steven M Leber
Journal:  Cerebrovasc Dis Extra       Date:  2015-05-21

Review 4.  Western Moyamoya Phenotype: A Scoping Review.

Authors:  Raphael Miller; Santiago R Unda; Ryan Holland; David J Altschul
Journal:  Cureus       Date:  2021-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.